Free Trial

Natixis Advisors LLC Raises Stock Holdings in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background
Remove Ads

Natixis Advisors LLC lifted its stake in The Clorox Company (NYSE:CLX - Free Report) by 6.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,296 shares of the company's stock after buying an additional 3,820 shares during the period. Natixis Advisors LLC owned approximately 0.05% of Clorox worth $10,930,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Brooklyn Investment Group boosted its stake in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC boosted its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc acquired a new stake in Clorox during the 4th quarter worth $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in Clorox during the 4th quarter worth $36,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

CLX stock traded down $0.46 during midday trading on Friday, hitting $144.88. 1,553,392 shares of the stock were exchanged, compared to its average volume of 1,208,595. The stock's 50-day moving average price is $152.84 and its 200-day moving average price is $159.77. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $17.85 billion, a price-to-earnings ratio of 39.58, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business earned $2.16 EPS. Research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.37%. Clorox's payout ratio is 133.33%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Barclays increased their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. Wells Fargo & Company increased their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $159.62.

Check Out Our Latest Research Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads